| Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study GA Roth, GA Mensah, CO Johnson, G Addolorato, E Ammirati, ... Journal of the American college of cardiology 76 (25), 2982-3021, 2020 | 6250* | 2020 |
| Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) RM Inciardi, L Lupi, G Zaccone, L Italia, M Raffo, D Tomasoni, DS Cani, ... JAMA cardiology 5 (7), 819-824, 2020 | 2210 | 2020 |
| Myocarditis and inflammatory cardiomyopathy: current evidence and future directions C Tschöpe, E Ammirati, B Bozkurt, ALP Caforio, LT Cooper, SB Felix, ... Nature Reviews Cardiology 18 (3), 169-193, 2021 | 801 | 2021 |
| Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document E Ammirati, M Frigerio, ED Adler, C Basso, DH Birnie, M Brambatti, ... Circulation: Heart Failure 13 (11), e007405, 2020 | 487 | 2020 |
| Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: multicenter Lombardy registry E Ammirati, M Cipriani, C Moro, C Raineri, D Pini, P Sormani, ... Circulation 138 (11), 1088-1099, 2018 | 320 | 2018 |
| 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 … Writing Committee, TJ Gluckman, NM Bhave, LA Allen, EH Chung, ... Journal of the American College of Cardiology 79 (17), 1717-1756, 2022 | 308 | 2022 |
| Eosinophilic myocarditis: characteristics, treatment, and outcomes M Brambatti, MV Matassini, ED Adler, K Klingel, PG Camici, E Ammirati Journal of the American College of Cardiology 70 (19), 2363-2375, 2017 | 263 | 2017 |
| Survival and left ventricular function changes in fulminant versus nonfulminant acute myocarditis E Ammirati, M Cipriani, M Lilliu, P Sormani, M Varrenti, C Raineri, ... Circulation 136 (6), 529-545, 2017 | 231 | 2017 |
| Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosis E Ammirati, F Moroni, GD Norata, M Magnoni, PG Camici Mediators of inflammation 2015, 2015 | 225 | 2015 |
| Myocarditis after BNT162b2 and mRNA-1273 vaccination KF Larson, E Ammirati, ED Adler, LT Cooper Jr, KN Hong, G Saponara, ... Circulation 144 (6), 506-508, 2021 | 224 | 2021 |
| Emerging role of high density lipoproteins as a player in the immune system GD Norata, A Pirillo, E Ammirati, AL Catapano Atherosclerosis 220 (1), 11-21, 2012 | 208 | 2012 |
| Fulminant versus acute nonfulminant myocarditis in patients with left ventricular systolic dysfunction E Ammirati, G Veronese, M Brambatti, M Merlo, M Cipriani, L Potena, ... Journal of the American College of Cardiology 74 (3), 299-311, 2019 | 194 | 2019 |
| Effector memory T cells are associated with atherosclerosis in humans and animal models E Ammirati, D Cianflone, V Vecchio, M Banfi, AC Vermi, M De Metrio, ... Journal of the American Heart Association 1 (1), e000125, 2012 | 182 | 2012 |
| The role of T and B cells in human atherosclerosis and atherothrombosis E Ammirati, F Moroni, M Magnoni, PG Camici Clinical & Experimental Immunology 179 (2), 173-187, 2015 | 167 | 2015 |
| Circulating CD4+CD25hiCD127lo Regulatory T-Cell Levels Do Not Reflect the Extent or Severity of Carotid and Coronary Atherosclerosis E Ammirati, D Cianflone, M Banfi, V Vecchio, A Palini, M De Metrio, ... Arteriosclerosis, thrombosis, and vascular biology 30 (9), 1832-1841, 2010 | 166 | 2010 |
| Cyclosporine in transplantation-a history of converging timelines. D Colombo, E Ammirati Journal of biological regulators and homeostatic agents 25 (4), 493-504, 2011 | 163 | 2011 |
| Prevalence, characteristics, and outcomes of COVID-19–associated acute myocarditis E Ammirati, L Lupi, M Palazzini, NS Hendren, JL Grodin, CV Cannistraci, ... Circulation 145 (15), 1123-1139, 2022 | 150 | 2022 |
| Obesity-induced metabolic stress leads to biased effector memory CD4+ T cell differentiation via PI3K p110δ-Akt-mediated signals C Mauro, J Smith, D Cucchi, D Coe, H Fu, F Bonacina, A Baragetti, ... Cell metabolism 25 (3), 593-609, 2017 | 138 | 2017 |
| Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives E Ammirati, R Contri, R Coppini, F Cecchi, M Frigerio, I Olivotto European journal of heart failure 18 (9), 1106-1118, 2016 | 136 | 2016 |
| Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7 A Vergani, S Tezza, F D’Addio, C Fotino, K Liu, M Niewczas, R Bassi, ... Circulation 127 (4), 463-475, 2013 | 130 | 2013 |
Maria FrigerioDir. Cardiologia 2- insuff. cardiaca e trapianto, De Gasperis CardioCenter, OspedaleBestätigte E-Mail-Adresse bei ospedaleniguarda.it
